dehydroepiandrosterone sulfate has been researched along with Cancer of the Uterus in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (75.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brody, S; Carlström, K; Lagrelius, A; Lunell, NO; Rosenborg, L | 1 |
Kettel, LM; Morales, AJ; Murphy, AA; Roberts, VJ; Yen, SS | 1 |
Eicher, W; Klinga, K; Mück, AO; Schmitt-Robe, B | 1 |
Benveniste, R; Ilekis, J; Moise, J; Scommegna, A | 1 |
James, VH; Jones, DL | 1 |
Milewich, L; Porter, JC | 1 |
Andreyko, JL; Blumenfeld, Z; Hricak, H; Jaffe, RB; Marshall, LA; Monroe, SE | 1 |
Baudier, MM; Chihal, HJ | 1 |
8 other study(ies) available for dehydroepiandrosterone sulfate and Cancer of the Uterus
Article | Year |
---|---|
Adrenal steroids, bone mineral content and endometrial pathology in postmenopausal women.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Bone and Bones; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endometrium; Estrone; Female; Forearm; Humans; Hydrocortisone; Menopause; Middle Aged; Minerals; Osteoporosis; Testosterone; Uterine Neoplasms | 1981 |
Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
Topics: Adolescent; Adult; Androstenedione; Bone Density; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Humans; Hysterectomy; Immunohistochemistry; Leiomyoma; Luteinizing Hormone; Middle Aged; Mifepristone; Myometrium; Progesterone; Receptors, Estradiol; Receptors, Progesterone; Testosterone; Uterine Neoplasms | 1993 |
[Subjective complaints and hormonal reactions in the first 6 weeks after hysterectomy].
Topics: Adult; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Hysterectomy; Luteinizing Hormone; Middle Aged; Ovarian Neoplasms; Ovariectomy; Postoperative Complications; Prospective Studies; Testosterone; Uterine Diseases; Uterine Neoplasms | 1992 |
The effect of dehydroepiandrosterone sulfate on de novo and low-density lipoprotein-stimulated progesterone secretion by human choriocarcinoma JEG-3 cells.
Topics: Cell Line; Cells, Cultured; Choriocarcinoma; Culture Media; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; In Vitro Techniques; Lipoproteins, LDL; Pregnancy; Pregnenolone; Progesterone; Trophoblasts; Uterine Neoplasms | 1986 |
Determination of dehydroepiandrosterone and dehydroepiandrosterone sulphate in blood and tissue. Studies of normal women and women with breast or endometrial cancer.
Topics: Adult; Age Factors; Aged; Body Weight; Breast Neoplasms; Circadian Rhythm; Cross Reactions; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endometrium; Female; Humans; Menopause; Menstruation; Middle Aged; Radioimmunoassay; Tissue Distribution; Uterine Neoplasms | 1987 |
In situ steroid sulfatase activity in human epithelial carcinoma cells of vaginal, ovarian, and endometrial origin.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Cell Line; Cystadenocarcinoma; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estrone; Female; Humans; Hydrolysis; Ovarian Neoplasms; Steryl-Sulfatase; Sulfatases; Uterine Neoplasms; Vaginal Neoplasms | 1987 |
Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
Topics: Adult; Androstenedione; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Evaluation; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Leiomyoma; Luteinizing Hormone; Magnetic Resonance Imaging; Nafarelin; Testosterone; Time Factors; Uterine Neoplasms | 1988 |
Polycystic ovary syndrome.
Topics: Androgens; Clomiphene; Contraceptives, Oral; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Follicle Stimulating Hormone; Hirsutism; Humans; Infertility, Female; Luteinizing Hormone; Menstruation Disturbances; Ovary; Polycystic Ovary Syndrome; Progestins; Risk; Uterine Neoplasms | 1985 |